Symmetry considerations in Markovian chemicals ‘in silico’ design (MARCH-INSIDE) I: central chirality codification, classification of ACE inhibitors and prediction of σ-receptor antagonist activities-Reference-Cited by-同舟云学术

Symmetry considerations in Markovian chemicals ‘in silico’ design (MARCH-INSIDE) I: central chirality codification, classification of ACE inhibitors and prediction of σ-receptor antagonist activities

Published:2003-07 Issue:3 Volume:27 Page:217-227
ISSN:1476-9271
Container-title:Computational Biology and Chemistry
language:en
Short-container-title:Computational Biology and Chemistry

Author:

Dı́az Humberto González,Sánchez Ivan Hernández,Uriarte Eugenio,Santana Lourdes

Publisher

Elsevier BV

Subject

Computational Mathematics,Organic Chemistry,Biochemistry,Structural Biology

Reference46 articles.

1. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

2. V.—On the Connection between Chemical Constitution and Physiological Action. Part. I.—On the Physiological Action of the Salts of the Ammonium Bases, derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia

3. Prediction of properties of chiral compounds by molecular topology

4. High Throughput Screening;Devlin,2000

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chirality Descriptors for Numerical Characterization of Enantiomers and Diastereomers;Synthesis Lectures on Mathematics & Statistics;2024-09-03

2. Tensor algebra-based geometric methodology to codify central chirality on organic molecules;SAR and QSAR in Environmental Research;2017-06-03

3. Relationship between molecular descriptors and the enthalpies of sublimation of natural amino acids;Russian Journal of Physical Chemistry A;2016-06-16

4. Evolution of Graph Theory-Based QSAR Methods and their Applications to the Search for New Antibacterial Agents;Current Topics in Medicinal Chemistry;2013-12-31

5. 3D QSAR Studies on Substituted Benzimidazole Derivatives as Angiotensin II-AT₁ Receptor Antagonist;Current Computer Aided-Drug Design;2013-08-01